Last10K.com

Bright Health Group Inc. (BHG) SEC Filing 10-Q Quarterly Report for the period ending Friday, September 30, 2022

SEC Filings

BHG Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

BHG Annual Reports

BHG Quarterly Reports

BHG Corporate News

Bright Health Group Inc.

HISTORY TOOLS
CIK: 1671284 Ticker: BHG


Exhibit 99.1
bhglogo_jpegxearningsx0802a.jpg

BRIGHT HEALTH GROUP REPORTS THIRD QUARTER 2022 RESULTS

•Revenue of $1.6 billion, up 51.3% from Q3'21, GAAP Net Loss of $259.4 million, Adjusted EBITDA Loss of $82.9 million
•Q2’22 Enterprise Medical Cost Ratio of 90.6%, a strong improvement from the prior year
•Lowering Full Year 2022 Enterprise Medical Cost Ratio guidance range to 90% to 92%
•Positively revising Full Year 2022 Adjusted EBITDA loss guidance range to $550 to $700 million


MINNEAPOLIS, MN (November 9, 2022)
(BUSINESSWIRE) – Bright Health Group, Inc. (“Bright Health Group” or the “Company”) (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported financial results for its third quarter ended September 30, 2022.

“Bright Health Group continued to deliver against our financial targets in the Third Quarter and we have confidence in our improved guidance for the year,” said Mike Mikan, President and CEO of Bright Health Group. “Our Medicare Advantage and NeueHealth businesses continued to outperform our expectations in the quarter. With our strengthened capital position and transition to a more focused business model, we expect to reach Adjusted EBITDA profitability in 2023 and continue to drive our differentiated Fully Aligned Care Model.”

Key Metrics

As of September 30,
20222021
Consumer and Patient Metrics
Bright HealthCare Commercial Consumers1,025,000600,000
Medicare Advantage Consumers125,000110,000
NeueHealth Value-Based Patients520,000170,000

Three Months EndedNine Months Ended
($ in thousands)September 30,September 30,
2022202120222021
Financial Metrics
Revenue$1,632,292$1,078,657$5,044,495$3,067,055
Medical Cost Ratio (1)
90.6 %103.0 %87.9 %90.3 %
Operating Cost Ratio18.2 %28.7 %22.3 %25.4 %
GAAP Net Loss (2)
$(259,361)$(296,722)$(691,320)$(364,990)
Adjusted EBITDA (non-GAAP)$(82,929)$(292,176)$(352,620)$(399,769)

(1)Medical Cost Ratio for the three months ended September 30, 2022 and 2021, include a 140 basis point and 540 basis point, respectively, unfavorable impact from COVID-19 related costs. Medical Cost Ratio for the

The following information was filed by Bright Health Group Inc. (BHG) on Wednesday, November 9, 2022 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Bright Health Group Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Bright Health Group Inc..

Continue

Assess how Bright Health Group Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Bright Health Group Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
M & A
Other
Filter Subcategory:
All
Expense
Cash Flow
Product
Earnings
Geography
Shares
Other
Inside Bright Health Group Inc.'s 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover Page
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Changes In Redeemable Preferred Stock And Shareholders' Equity (Deficit)
Condensed Consolidated Statements Of Comprehensive Income (Loss)
Condensed Consolidated Statements Of Comprehensive Income (Loss) (Parenthetical)
Condensed Consolidated Statements Of Income (Loss)
Business Combinations
Business Combinations (Tables)
Business Combinations - Narrative (Details)
Business Combinations - Schedule Of Business Acquisitions (Details)
Business Combinations - Schedule Of Pro Forma Revenue And Net Loss (Details)
Commitments And Contingencies
Commitments And Contingencies (Details)
Direct Contracting
Direct Contracting (Details)
Direct Contracting (Tables)
Direct Contracting - Narrative (Details)
Fair Value Measurements
Fair Value Measurements (Tables)
Fair Value Measurements - Schedule Of Change In Fair Value Of Contingent Consideration (Details)
Fair Value Measurements - Schedule Of Fair Value Measurement For Assets On A Recurring Basis (Details)
Fair Value Measurements - Schedule Of Fair Value Measurement Of Financial Instruments Not Measured On A Recurring Basis (Details)
Goodwill And Intangible Assets
Goodwill And Intangible Assets (Tables)
Goodwill And Intangible Assets - Narrative (Details)
Goodwill And Intangible Assets - Schedule Of Definite-Lived Intangible Assets (Details)
Goodwill And Intangible Assets - Schedule Of Goodwill (Details)
Goodwill And Intangible Assets - Schedule Of Intangible Asset Amortization Expense (Details)
Income Taxes
Income Taxes (Details)
Investments
Investments (Tables)
Investments - Narrative (Details)
Investments - Schedule Of Available-For-Sale Securities Maturities (Details)
Investments - Schedule Of Investment Securities (Details)
Investments - Schedule Of Investments In Continuous Loss Position (Details)
Medical Costs Payable
Medical Costs Payable (Tables)
Medical Costs Payable - Change In Medical Costs Payable (Details)
Medical Costs Payable - Components Of Medical Costs Payable (Details)
Medical Costs Payable - Narrative (Details)
Net Loss Per Share
Net Loss Per Share (Tables)
Net Loss Per Share - Schedule Of Antidilutive Securities Excluded From Net Loss Per Share (Details)
Net Loss Per Share - Schedule Of Net Loss Per Share (Details)
Organization And Basis Of Presentation
Organization And Basis Of Presentation (Policies)
Organization And Basis Of Presentation (Tables)
Organization And Basis Of Presentation - Narrative (Details)
Organization And Basis Of Presentation - Schedule Of Operating Costs (Details)
Redeemable Convertible Preferred Stock
Redeemable Convertible Preferred Stock (Details)
Redeemable Noncontrolling Interest
Redeemable Noncontrolling Interest (Tables)
Redeemable Noncontrolling Interest - Schedule Of Redeemable Noncontrolling Interest (Details)
Segments And Geographic Information
Segments And Geographic Information (Tables)
Segments And Geographic Information - Narrative (Details)
Segments And Geographic Information - Schedule Of Segment Information (Details)
Share-Based Compensation
Share-Based Compensation (Tables)
Share-Based Compensation - Narrative (Details)
Share-Based Compensation - Schedule Of Rsu And Psu Activity (Details)
Share-Based Compensation - Schedule Of Stock Option Activity (Details)
Share-Based Compensation - Schedule Of Stock Option Valuation Assumptions (Details)
Short-Term Borrowings
Short-Term Borrowings (Details)
Subsequent Events
Subsequent Events - Narrative (Details)

Material Contracts, Statements, Certifications & more

Bright Health Group Inc. provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
Exhibit 32.2: Section 1350 Certification
Ticker: BHG
CIK: 1671284
Form Type: 10-Q Quarterly Report
Accession Number: 0001671284-22-000068
Submitted to the SEC: Mon Nov 14 2022 4:32:06 PM EST
Accepted by the SEC: Mon Nov 14 2022
Period: Friday, September 30, 2022
Industry: Hospital And Medical Service Plans

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/bhg/0001671284-22-000068.htm